105¦~5¤ë¸¹ ¹D ªk ªk °T (289)

DEEP & FAR

 

 

 
35 USC¡±101¤U±M§Q¾A®æ©Êªº«ùÄòºt¶i                                   
                                  

 

§d¨Ø¬Â ±M§Q¤G²Õ¥D¥ô

¡D¥xÆW¤j¾Ç¹AÃÀ¨t¾Ç¤h

¡D¥xÆW¤j¾Ç¹AÃÀ©ÒºÓ¤h

 

I. «e¨¥

¦Û2010¦~¥H¨Ó¡A¥H¤Î³Ìªñ¦b2014¦~6¤ë¡A³Ì°ªªk°|¤wµo¥¬­­©w35 USC¡±101¤U¦UºØµo©ú±M§Q¾A®æ©Êªº¥|ÂI¨£¸Ñ¡C¦b¸Ñ¨Mªk°|¼Æ¤Q¦~¤@ª½¬Û¹ï¥¼Ä²¤ÎªºÄ³ÃD¤¤¡A³o¨Ç³Ìªñªº¨M©w¤w¸gÅãµÛ¦a§ïÅܸó¶V±q°Ó·~¤èªk¤Î³nÅé¨ìÂå¾Ç¶EÂ_¤ÎªvÀø¤èªk¡B¦A¨ìÃĪ«¤Î¥Íª«§Þ³N³Ð·sªº¦h­Ó§Þ³N³¡ªùªº¦UºØµo©ú¦b±M§Q«OÅ@¤è­±¤W¾A®æªºµ{«×¡A¦Ó¤£½×¬O§_¤w²Å¦X¥i±M§Q©Êªº¨ä¥Lªk©w­n¨D¡]·s¿o©Ê¡A«DÅã¦Ó©ö¨£©Ê¡A©ú½T©Ê¡^¡C ¤U¯Åªk°|»PPTO±µµÛÄ~Äò¹Á¸Õ¸àÄÀ³Ì°ªªk°|ªk°|ªº«ü«n¡A¥H¹ê²{·Ç¾Úªk¤¤ªº³o¨ÇÅãµÛ§ïÅÜ¡C

¥»¤å¤¶²Ð¤F¦Ûªk°|2013¦~¦bAss¡¦n for Molecular Pathology v. Myriad Genetics, Inc.¤¤ªº§P¨M¥H¨Ó±M§Q¾A®æ©Ê³v¨Bºt¤Æµo®iªº·§­z¡A¦bAss¡¦n for Molecular Pathology v. Myriad Genetics, Inc.¤¤¡Aªk°|»{¬°¦b²Ä101±ø¤U¡A°ò¦]¦b±Â¤©±M§Q¤è­±¬O«D¾A®æªº¡C­º¥ý¡A©ó¦^À³¨Ó¦Û¤½²³ªº§åµû·N¨£¥H¤Î¨ä«áªº³Ì°ªªk°|¥ý¨Ò¤¤¡A¨ä°Q½×¤F¦bMyriad ¤Îªk°|2012¦~¦bMayo Collaborative Servs. v. Prometheus Labs., Inc.¤¤ªº§P¨M¤§«áPTOµo¥¬ªº«ü«n¡B¥H¤ÎPTO¹ï¸Ó«ü«n¥¿¦b¶i¦æ¤¤ªº­×­q¡C¨ä¤]°Q½×¤U¯Åªk°|¦bMyriadªº±M§QÅv¤H¥¿¸Õ¹Ï±j¨î°õ¦æ»PMyriadªk°|¼f²z¤Uªº±M§Q½Ð¨D¶µ¬ÛÃö¡B¦ý»P¨ä¿W¥ßªº¨º¨Ç±M§Q½Ð¨D¶µªº®×¨Ò¡C³Ì«á¡A¨ä½×­z¤F³Ì°ªªk°|¹ïAlice Corp. Pty. v. CLS Bank Int¡¦l¤¤¥Ñ¹q¸£¹ê¬Iªº¡§©â¶H¡¨·§©Àªº±M§Q«D¾A®æ©Ê¤Wªº³Ì·sµô¨M¡B¥H¤Î¸Ó§P¨M»PMyriad¥H¤ÎMayoªºÃö«Y¡C